Neoplasm of Lung: Clinical Trials

1 trial for Neoplasm of Lung, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Neoplasm of Lung: new trials by email Literature Review of Neoplasm of Lung trials Research Report on Neoplasm of Lung

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab
APX005M, Nivolumab - Cancer, Non Small Cell Lung Cancer Metastatic
Phase 1 / Phase 2CompletedApexigen America, Inc.1402017-07-102023-12-26

Narrower conditions

Lung Neoplasms (1)  ·  Melanoma (1)  ·  Neoplasms (1)

Broader conditions

Lung Diseases (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neuroectodermal Tumors (1)  ·  Neuroendocrine Tumors (1)  ·  Nevi and Melanomas (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Neoplasms (1)  ·  Skin Diseases (1)  ·  Skin Neoplasms (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Thoracic Neoplasms (1)

Interventions

Nivolumab (1)  ·  sotigalimab (1)

Sponsors

Apexigen America, Inc. (1)

Countries

Spain (1)  ·  United States (1)